Ingileif Jónsdóttir

ORCID: 0000-0001-8339-150X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Bacterial Infections and Vaccines
  • Genetic Associations and Epidemiology
  • Respiratory viral infections research
  • Asthma and respiratory diseases
  • Osteoarthritis Treatment and Mechanisms
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Response and Inflammation
  • T-cell and B-cell Immunology
  • Immunodeficiency and Autoimmune Disorders
  • Immune Cell Function and Interaction
  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Immunotherapy and Immune Responses
  • Systemic Lupus Erythematosus Research
  • IL-33, ST2, and ILC Pathways
  • Growth Hormone and Insulin-like Growth Factors
  • Genomics and Rare Diseases
  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • Pediatric health and respiratory diseases
  • Glycosylation and Glycoproteins Research
  • Cytokine Signaling Pathways and Interactions
  • COVID-19 Clinical Research Studies
  • Epigenetics and DNA Methylation

deCODE Genetics (Iceland)
2016-2025

University of Iceland
2016-2025

National University Hospital of Iceland
2014-2024

Reykjavík University
2002-2024

Amgen (Germany)
2016-2023

RMIT University
2023

University of British Columbia
2020

Directorate of Health
2020

Faculty (United Kingdom)
2016

Finnish Institute of Occupational Health
2011

BackgroundDuring the current worldwide pandemic, coronavirus disease 2019 (Covid-19) was first diagnosed in Iceland at end of February. However, data are limited on how SARS-CoV-2, virus that causes Covid-19, enters and spreads a population.MethodsWe targeted testing to persons living who were high risk for infection (mainly those symptomatic, had recently traveled high-risk countries, or contact with infected persons). We also carried out population screening using two strategies: issuing...

10.1056/nejmoa2006100 article EN New England Journal of Medicine 2020-04-14

Little is known about the nature and durability of humoral immune response to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).We measured antibodies in serum samples from 30,576 persons Iceland, using six assays (including two pan-immunoglobulin [pan-Ig] assays), we determined that appropriate measure seropositivity was a positive result both pan-Ig assays. We tested 2102 collected 1237 up 4 months after diagnosis by quantitative polymerase-chain-reaction (qPCR)...

10.1056/nejmoa2026116 article EN New England Journal of Medicine 2020-09-01
Adrienne Tin Jonathan Marten Victoria L. Halperin Kuhns Yong Li Matthias Wuttke and 95 more Holger Kirsten Karsten B. Sieber Chengxiang Qiu Mathias Gorski Zhi Yu Ayush Giri Garðar Sveinbjörnsson Man Li Audrey Y. Chu Anselm Hoppmann Luke J. O’Connor Bram P. Prins Teresa Nutile Damia Noce Masato Akiyama Massimiliano Cocca Sahar Ghasemi Peter J. van der Most Katrin Horn Yizhe Xu Christian Fuchsberger Sanaz Sedaghat Saima Afaq Najaf Amin Johan Ärnlöv Stephan J. L. Bakker Nisha Bansal Daniela Baptista Sven Bergmann Mary L. Biggs Ginevra Biino Eric Boerwinkle Erwin P. Böttinger Thibaud Boutin Marco Brumat Ralph Burkhardt Eric Campana Archie Campbell Harry Campbell Robert J. Carroll Eulalia Catamo John C. Chambers Marina Ciullo Maria Pina Concas Josef Coresh Tanguy Corre Daniele Cusi Cinzia Sala Martin H. de Borst Alessandro De Grandi Renée de Mutsert Aiko P. J. de Vries Graciela Delgado Ayşe Demirkan Olivier Devuyst Katalin Dittrich Kai‐Uwe Eckardt Georg Ehret Karlhans Endlich Michele K. Evans Ron T. Gansevoort Paolo Gasparini Vilmantas Giedraitis Christian Gieger Giorgia Girotto Martin Gögele Scott D. Gordon Daníel F. Guðbjartsson Vilmundur Guðnason Toomas Haller Pavel Hamet Tamara B. Harris Caroline Hayward Andrew A. Hicks Edith Hofer Hilma Hólm Wei Huang Nina Hutri‐Kähönen Shih‐Jen Hwang M. Arfan Ikram Raychel M. Lewis Erik Ingelsson Jóhanna Jakobsdóttir Ingileif Jónsdóttir Helgi Jónsson Peter K. Joshi Navya Shilpa Josyula Bettina Jung Mika Kähönen Yoichiro Kamatani Masahiro Kanai Shona M. Kerr Wieland Kieß Marcus E. Kleber Wolfgang Köenig

10.1038/s41588-019-0504-x article EN Nature Genetics 2019-10-01
Bjarni V. Halldórsson Hannes P. Eggertsson Kristjan H. S. Moore Hannes Hauswedell Ögmundur Eiríksson and 74 more Magnús Ö. Úlfarsson Gunnar Pálsson Marteinn T. Hardarson Ásmundur Oddsson Brynjar Ö. Jensson Snædís Kristmundsdóttir Brynja D. Sigurpalsdottir Ólafur Andri Stefánsson Doruk Beyter Guillaume Holley Vinicius Tragante Arnaldur Gylfason Pall I. Olason Florian Zink Margret Asgeirsdottir Sverrir T. Sverrisson Brynjar Sigurdsson Sigurjón A. Guðjónsson Gunnar Sigurðsson Gísli H. Halldórsson Garðar Sveinbjörnsson Kristján Norland Unnur Styrkársdóttir Droplaug N. Magnúsdóttir Steinunn Snorradóttir Kári Kristinsson Emilia Sobech Helgi Jónsson Árni Jón Geirsson Ísleifur Ólafsson Pálmi V. Jónsson Ole Birger Pedersen Christian Erikstrup Søren Brunak Sisse Rye Ostrowski Steffen Andersen Karina Banasik Kristoffer Sølvsten Burgdorf Maria Didriksen Khoa Manh Dinh Christian Erikstrup Daníel F. Guðbjartsson Thomas Hansen Henrik Hjalgrim Gregor B. E. Jemec Poul Jennum Pär I. Johansson Margit Anita Hørup Larsen Susan Mikkelsen Kasper Nielsen Mette Nyegaard Sisse Rye Ostrowski Susanne Gjørup Sækmose Erik Sørensen Unnur Þorsteinsdóttir Mie Topholm Brun Henrik Ullum Thomas Werge Guðmar Þorleifsson Frosti Jónsson Páll Melsted Ingileif Jónsdóttir Þórunn Rafnar Hilma Hólm Hreinn Stefánsson Jona Saemundsdottir Daníel F. Guðbjartsson Ólafur Þ. Magnússon Gísli Másson Unnur Þorsteinsdóttir Agnar Helgason Hákon Jónsson Patrick Sulem Kári Stéfansson

Detailed knowledge of how diversity in the sequence human genome affects phenotypic depends on a comprehensive and reliable characterization both sequences variation. Over past decade, insights into this relationship have been obtained from whole-exome sequencing or whole-genome large cohorts with rich data1,2. Here we describe analysis 150,119 individuals UK Biobank3. This constitutes set high-quality variants, including 585,040,410 single-nucleotide polymorphisms, representing 7.0% all...

10.1038/s41586-022-04965-x article EN cc-by Nature 2022-07-20
Louise V. Wain Nick Shrine María Soler Artigas A. Mesut Erzurumluoglu Boris Noyvert and 95 more Lara Bossini‐Castillo Ma’en Obeidat Amanda P. Henry Michael A. Portelli Robert J. Hall Charlotte K. Billington Tracy L. Rimington Anthony G. Fenech Catherine John Tineka Blake Victoria E. Jackson Richard J. Allen Bram P. Prins Archie Campbell David J. Porteous Marjo‐Riitta Järvelin Matthias Wielscher Anthony James Jennie Hui Nicholas J. Wareham Wei Zhao James F. Wilson Peter K. Joshi Beate Stubbe Rajesh Rawal Holger Schulz Medea Imboden Nicole Probst‐Hensch Stefan Karrasch Christian Gieger Ian J. Deary Sarah E. Harris Jonathan Marten Igor Rudan Stefan Enroth Ulf Gyllensten Shona M. Kerr Ozren Polašek Mika Kähönen Ida Surakka Véronique Vitart Caroline Hayward Terho Lehtimäki Olli T. Raitakari David M. Evans Alex Henderson Craig E. Pennell Carol A. Wang Peter D. Sly Emily S. Wan Robert Busch Brian D. Hobbs Augusto A. Litonjua David Sparrow Amund Gulsvik Per Bakke James D. Crapo Terri H. Beaty Nadia N. Hansel Rasika A. Mathias Ingo Ruczinski Kathleen C. Barnes Yohan Bossé Philippe Joubert Maarten van den Berge Corry‐Anke Brandsma Peter D. Paré Don D. Sin David C. Nickle Ke Hao Omri Gottesman Frederick E. Dewey Shannon Bruse David J. Carey H. Lester Kirchner Stefan Jonsson Guðmar Þorleifsson Ingileif Jónsdóttir Þórarinn Gíslason Kári Stéfansson Claudia Schurmann Girish N. Nadkarni Erwin P. Böttinger Ruth J. F. Loos Robin Walters Zhengming Chen Iona Y. Millwood Julien Vaucher Om Kurmi Liming Li Anna Hansell Christopher E. Brightling Eleftheria Zeggini Michael H. Cho Edwin K. Silverman

10.1038/ng.3787 article EN Nature Genetics 2017-02-06

Human IgG3 displays the strongest effector functions of all IgG subclasses but has a short half-life for unresolved reasons. Here we show that binds to IgG-salvage receptor (FcRn), FcRn-mediated transport and rescue is inhibited in presence IgG1 due intracellular competition between IgG3. We reveal this occurs because single amino acid difference at position 435, where an arginine instead histidine found other subclasses. While R435 increases binding FcRn neutral pH, it decreases acidic...

10.1038/ncomms1608 article EN cc-by-nc-nd Nature Communications 2011-12-20

The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for multiple sclerosis (MS). Here, we find that hypomethylated and predominantly expressed in monocytes among carriers of DRB1*15:01. A differentially methylated region (DMR) encompassing HLA-DRB1 exon 2 particularly affected displays methylation-sensitive regulatory properties vitro. Causal inference Mendelian randomization provide evidence HLA variants mediate MS via changes DMR modify expression. Meta-analysis...

10.1038/s41467-018-04732-5 article EN cc-by Nature Communications 2018-06-13

Lipoprotein(a) [Lp(a)] is a causal risk factor for cardiovascular diseases that has no established therapy. The attribute of Lp(a) affects not established. Low levels have been associated with type 2 diabetes (T2D). This study investigated whether conferred by molar concentration or apolipoprotein(a) [apo(a)] size, and the relationship between T2D causal. was case-control 143,087 Icelanders genetic information, including 17,715 coronary artery disease (CAD) 8,734 T2D. used measured...

10.1016/j.jacc.2019.10.019 article EN cc-by-nc-nd Journal of the American College of Cardiology 2019-12-01

Nonalcoholic fatty liver (NAFL) and its sequelae are growing health problems. We performed a genome-wide association study of NAFL, cirrhosis hepatocellular carcinoma, integrated the findings with expression proteomic data. For we utilized 9,491 clinical cases proton density fat fraction extracted from 36,116 magnetic resonance images. identified 18 sequence variants associated NAFL 4 cirrhosis, found rare, protective, predicted loss-of-function in MTARC1 GPAM, underscoring them as potential...

10.1038/s41588-022-01199-5 article EN cc-by Nature Genetics 2022-10-24
Coming Soon ...